Get the Stockscreener App
24.30
0.00%
0.03
ARK Genomic Revolution ETF stock is traded at $24.30, with a volume of 1.01M.
It is up +0.00% in the last 24 hours and down -2.37% over the past month.
The investment seeks long-term growth of capital.
The fund is an actively-managed exchange-traded fund ("ETF") that will invest under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including healthcare, information technology, materials, energy and consumer discretionary, that are relevant to the fund's investment theme of the genomics revolution ("Genomics Revolution Companies"). It is non-diversified.
See More
Previous Close:
$24.27
Open:
$24.07
24h Volume:
1.01M
Relative Volume:
0.53
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+1.38%
1M Performance:
-2.37%
6M Performance:
-3.08%
1Y Performance:
-6.80%
1-Day Range:
$23.64
$24.41
1-Week Range:
$23.14
$24.41
52-Week Range:
$22.33
$34.37
ARK Genomic Revolution ETF Stock (ARKG) Company Profile
Name
ARK Genomic Revolution ETF
Sector
Industry
Phone
855-406-1506
Address
-
ARK Genomic Revolution ETF Stock (ARKG) Latest News
Cathie Wood Buys $35 Million Of Amazon, Targets Crypto; Sells $42 Million Of This Stock - MSN
Cathie Wood's Ark Innovation, Genomic ETFs Celebrate 10 Years: How Annual Returns Stack Up Against S&P 500 - Benzinga
Cathie Wood's Sky-High Vision: Dumps Shares Of Cybercab Touting Tesla For This eVTOL Play - Yahoo Finance
Best Biotech ETFs to Watch Right Now - The Motley Fool
7 popular thematic ETFs: Here’s how to invest in some of the hottest trends - MSN
Cathie Wood Continues To Sell Shares Of Jack Dorsey's Bitcoin-Focused Company Block — Ark Also Dumps Moderna, Robinhood Stock - Benzinga
(ARKG) Investment Analysis - Stock Traders Daily
Cathie Wood's Ark Invest Dumps Over $9M In Moderna Stock — Even With Post-COVID Plans On The Table - Yahoo Finance
Interest Rate Regimes And ARKG: Underperformance Explained (BATS:ARKG) - Seeking Alpha
ARK Genomic Revolution ETF (BATS:ARKG) Shares Sold by Capital Market Strategies LLC - Defense World
Learn to Evaluate (ARKG) using the Charts - Stock Traders Daily
ARK Invest teams up with eToro to launch portfolio of ETFs - ETF Stream
ARK Invest Teams Up With eToro to Debut Portfolio of ETFs - Yahoo Finance
Cathie Wood's Ark Invest Dumps Palantir Shares Amidst S&P 500 Inclusion And Extended AI Alliance - Benzinga
(ARKG) Proactive Strategies - Stock Traders Daily
Bridges Investment Management Inc. Has $332,000 Stock Holdings in ARK Genomic Revolution ETF (BATS:ARKG) - Defense World
Forget Quantum-Si Stock, Olink Acquirer Thermo Fisher Is a Better Long-Term Investment - MSN
5 Best ETFs Tracking CRISPR Gene Editing - The Motley Fool
Made-in-America Industrial Bets Are Dethroning the Likes of ARKK - Wealth Management
In the age of new tech, old-economy industrial bets still thriving - Financial Post
In Age of New Tech, Old-Economy Industrial Bets Still Thriving (ARKK, PAVE) - Bloomberg
How Rich Is Cathie Wood? What To Know About the Famed Stock Picker and ARK Invest CEO - MSN
908 Devices: Key Investor Now Selling (NASDAQ:MASS) - Seeking Alpha
Cathie Wood's Stock Shuffle: 1 Stock She's Loving, 1 She's Leaving - 24/7 Wall St.
Cathie Wood’s ARK Invest Europe Suffers Slow Start - Yahoo Finance
Cathie Wood's ARK sells CareDx, buys Recursion Pharmaceuticals stock By Investing.com - Investing.com UK
Cathie Wood's ARK sells CareDx, buys Recursion Pharmaceuticals stock - Investing.com
Cathie Wood’s ARK Invest Europe suffers slow start - ETF Stream
Should You Follow Cathie Wood Into This AI Diagnostics Stock? - Nasdaq
When the Price of (ARKG) Talks, People Listen - Stock Traders Daily
Almost Every Ark Fund Is Now Underperforming The Overall Market. Here's Why. - MSN
Biotech Stock Soars 60% in 2024: Cathie Wood’s Bold Investment - MarketBeat
First Horizon Advisors Inc. Has $109,000 Stock Position in ARK Genomic Revolution ETF (BATS:ARKG) - Defense World
APA (APA) – Investment Analysts’ Weekly Ratings Changes - Defense World
Wealth Enhancement Advisory Services LLC Buys 4,305 Shares of ARK Genomic Revolution ETF (BATS:ARKG) - Defense World
The Zacks Analyst Blog Highlights Invesco DWA Technology Momentum ETF, Strive U.S. Semiconductor ETF, Invesco PHLX Semiconductor ETF, VanEck Vectors Semiconductor ETF and ARK Genomic Revolution ETF - Yahoo Finance
5 Technology ETFs at the Forefront of the August Rebound - Nasdaq
ARK Genomic Revolution ETF Stock (ARKG) Financials Data
There is no financial data for ARK Genomic Revolution ETF (ARKG). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.74%
Cap:
|
Volume (24h):